BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bartoletti M, Giannella M, Tedeschi S, Viale P. Multidrug-Resistant Bacterial Infections in Solid Organ Transplant Candidates and Recipients. Infectious Disease Clinics of North America 2018;32:551-80. [DOI: 10.1016/j.idc.2018.04.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Broom A, Peterie M, Kenny K, Broom J, Kelly-hanku A, Lafferty L, Treloar C, Applegate T. Vulnerability and antimicrobial resistance. Critical Public Health. [DOI: 10.1080/09581596.2022.2123733] [Reference Citation Analysis]
2 Freire MP, Rinaldi M, Terrabuio DRB, Furtado M, Pasquini Z, Bartoletti M, de Oliveira TA, Nunes NN, Lemos GT, Maccaro A, Siniscalchi A, Laici C, Cescon M, D Albuquerque LAC, Morelli MC, Song ATW, Abdala E, Viale P, Filho ADPC, Giannella M. Prediction models for carbapenem-resistant Enterobacterales carriage at liver transplantation: A multicenter retrospective study. Transpl Infect Dis 2022;:e13920. [PMID: 35942941 DOI: 10.1111/tid.13920] [Reference Citation Analysis]
3 So M, Walti L. Challenges of Antimicrobial Resistance and Stewardship in Solid Organ Transplant Patients. Curr Infect Dis Rep. [DOI: 10.1007/s11908-022-00778-1] [Reference Citation Analysis]
4 Isles NS, Mu A, Kwong JC, Howden BP, Stinear TP. Gut microbiome signatures and host colonization with multidrug-resistant bacteria. Trends in Microbiology 2022. [DOI: 10.1016/j.tim.2022.01.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Nanayakkara AK, Boucher HW, Fowler VG Jr, Jezek A, Outterson K, Greenberg DE. Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward. CA Cancer J Clin 2021;71:488-504. [PMID: 34546590 DOI: 10.3322/caac.21697] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
6 Giannella M, Bartoletti M, Conti M, Righi E. Carbapenemase-producing Enterobacteriaceae in transplant patients. J Antimicrob Chemother 2021;76:i27-39. [PMID: 33534881 DOI: 10.1093/jac/dkaa495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Karruli A, de Cristofaro J, Andini R, Iossa D, Bernardo M, Amarelli C, Mattucci I, Zampino R, Zarrilli R, Durante-Mangoni E. Risk Factors and Outcome of Multidrug-Resistant Infections after Heart Transplant: A Contemporary Single Center Experience. Microorganisms 2021;9:1210. [PMID: 34205082 DOI: 10.3390/microorganisms9061210] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Bavaro DF, Belati A, Diella L, Stufano M, Romanelli F, Scalone L, Stolfa S, Ronga L, Maurmo L, Dell'Aera M, Mosca A, Dalfino L, Grasso S, Saracino A. Cefiderocol-Based Combination Therapy for "Difficult-to-Treat" Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives. Antibiotics (Basel) 2021;10:652. [PMID: 34072342 DOI: 10.3390/antibiotics10060652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
9 Aslam S. Bacteriophage therapy as a treatment option for transplant infections. Curr Opin Infect Dis 2020;33:298-303. [PMID: 32657966 DOI: 10.1097/QCO.0000000000000658] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Kitano T, Science M, Nalli N, Timberlake K, Allen U, Teoh CW, Campigotto A. Solid organ transplant-specific antibiogram in a tertiary pediatric hospital in Canada. Pediatr Transplant 2021;25:e13980. [PMID: 33528088 DOI: 10.1111/petr.13980] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 . Anforderungen an die Infektionsprävention bei der medizinischen Versorgung von immunsupprimierten Patienten : Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2021;64:232-64. [PMID: 33394069 DOI: 10.1007/s00103-020-03265-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Cairns KA, Hall V, Martin GE, Griffin DWJ, Stewart JD, Khan SF, Abbott IJ, Meher-Homji Z, Morrissey CO, Sia C, Love J, Corallo CE, Bergin P, Sharma A, Basu G, Spencer A, Peleg AY. Treatment of invasive IMP-4 Enterobacter cloacae infection in transplant recipients using ceftazidime/avibactam with aztreonam: A case series and literature review. Transpl Infect Dis 2021;23:e13510. [PMID: 33217119 DOI: 10.1111/tid.13510] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Law N, Aslam S. Phage Therapy: Primer and Role in the Treatment of MDROs. Curr Infect Dis Rep 2020;22. [DOI: 10.1007/s11908-020-00742-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Correa-Martínez CL, Becker F, Schwierzeck V, Mellmann A, Brockmann JG, Kampmeier S. Donor-derived vancomycin-resistant enterococci transmission and bloodstream infection after intestinal transplantation. Antimicrob Resist Infect Control 2020;9:180. [PMID: 33160394 DOI: 10.1186/s13756-020-00845-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Freire MP, Song ATW, Oshiro ICV, Andraus W, D'Albuquerque LAC, Abdala E. Surgical site infection after liver transplantation in the era of multidrug-resistant bacteria: what new risks should be considered? Diagn Microbiol Infect Dis 2021;99:115220. [PMID: 33045498 DOI: 10.1016/j.diagmicrobio.2020.115220] [Reference Citation Analysis]
16 Alagna L, Palomba E, Mangioni D, Bozzi G, Lombardi A, Ungaro R, Castelli V, Prati D, Vecchi M, Muscatello A, Bandera A, Gori A. Multidrug-Resistant Gram-Negative Bacteria Decolonization in Immunocompromised Patients: A Focus on Fecal Microbiota Transplantation. Int J Mol Sci 2020;21:E5619. [PMID: 32764526 DOI: 10.3390/ijms21165619] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
17 Abdo-Cuza AA, Gómez-Bravo MA, Pérez-Bernal JB, Suárez-López J, Gómez-Peire F, Leiva-Torres JL, Bejerano-Gil N, Leal-Alpizar G, Espinosa-Nodarse N, Castellanos-Gutiérrez R. Health Care-Associated Infection in Solid Organ Transplant Recipients. Transplant Proc 2020;52:509-11. [PMID: 32035674 DOI: 10.1016/j.transproceed.2019.12.010] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Chen W, Sun L, Guo L, Cao B, Liu Y, Zhao L, Lu B, Li B, Chen J, Wang C. Clinical outcomes of ceftazidime-avibactam in lung transplant recipients with infections caused by extensively drug-resistant gram-negative bacilli. Ann Transl Med 2020;8:39. [PMID: 32154284 DOI: 10.21037/atm.2019.10.40] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
19 Pérez-Nadales E, Gutiérrez-Gutiérrez B, Natera AM, Abdala E, Reina Magalhães M, Mularoni A, Monaco F, Camera Pierrotti L, Pinheiro Freire M, Iyer RN, Mehta Steinke S, Grazia Calvi E, Tumbarello M, Falcone M, Fernández-Ruiz M, María Costa-Mateo J, Rana MM, Mara Varejão Strabelli T, Paul M, Carmen Fariñas M, Clemente WT, Roilides E, Muñoz P, Dewispelaere L, Loeches B, Lowman W, Tan BH, Escudero-Sánchez R, Bodro M, Antonio Grossi P, Soldani F, Gunseren F, Nestorova N, Pascual Á, Martínez-Martínez L, Aguado JM, Rodríguez-Baño J, Torre-Cisneros J; REIPI/INCREMENT-SOT Investigators. Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia. Am J Transplant 2019. [PMID: 31891235 DOI: 10.1111/ajt.15769] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
20 Maddila S, Gorle S, Jonnalagadda SB. Drug screening of rhodanine derivatives for antibacterial activity. Expert Opin Drug Discov 2020;15:203-29. [PMID: 31777321 DOI: 10.1080/17460441.2020.1696768] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 4.3] [Reference Citation Analysis]
21 Cai YS, Xiao H, Zhang S, Li M, Liang SM, Shi ZR, Du CY. Carbapenem-resistant Klebsiella pneumoniae infection causing rupture of graft artery in solid organ recipients: Case report and review of literature. Medicine (Baltimore) 2019;98:e17878. [PMID: 31702658 DOI: 10.1097/MD.0000000000017878] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Zahar J. Prévention du risque infectieux chez les patients atteints d’insuffisance rénale chronique. Néphrologie & Thérapeutique 2019;15:S21-6. [DOI: 10.1016/j.nephro.2019.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]